Danaher Corporation (NYSE:DHR) insider William King sold 7,458 shares of the company’s stock in a transaction on Friday, July 21st. The stock was sold at an average price of $82.97, for a total value of $618,790.26. Following the completion of the sale, the insider now owns 18,245 shares of the company’s stock, valued at $1,513,787.65. The sale was disclosed in a filing with the SEC, which is available at the SEC website.

Shares of Danaher Corporation (NYSE DHR) traded down 0.05% on Friday, hitting $80.87. The stock had a trading volume of 2,861,306 shares. The company has a market cap of $56.18 billion, a price-to-earnings ratio of 25.81 and a beta of 1.03. The stock has a 50 day moving average price of $82.32 and a 200-day moving average price of $84.22. Danaher Corporation has a 12-month low of $75.71 and a 12-month high of $88.01.

Danaher Corporation (NYSE:DHR) last announced its quarterly earnings results on Thursday, July 20th. The conglomerate reported $0.99 earnings per share (EPS) for the quarter, topping the Zacks’ consensus estimate of $0.97 by $0.02. Danaher Corporation had a return on equity of 11.15% and a net margin of 12.63%. The company had revenue of $4.51 billion during the quarter, compared to the consensus estimate of $4.50 billion. During the same period in the previous year, the business earned $0.90 EPS. Danaher Corporation’s revenue for the quarter was up 6.3% on a year-over-year basis. On average, equities analysts expect that Danaher Corporation will post $3.95 earnings per share for the current year.

COPYRIGHT VIOLATION WARNING: “Danaher Corporation (NYSE:DHR) Insider Sells $618,790.26 in Stock” was originally posted by The Cerbat Gem and is owned by of The Cerbat Gem. If you are accessing this news story on another website, it was illegally copied and republished in violation of US and international trademark and copyright legislation. The legal version of this news story can be viewed at https://www.thecerbatgem.com/2017/08/19/danaher-corporation-nysedhr-insider-william-king-sells-7458-shares-updated-updated-updated.html.

Several hedge funds have recently bought and sold shares of DHR. Toronto Dominion Bank boosted its stake in Danaher Corporation by 24.4% in the second quarter. Toronto Dominion Bank now owns 221,423 shares of the conglomerate’s stock worth $18,684,000 after buying an additional 43,429 shares during the period. Dynamic Technology Lab Private Ltd boosted its stake in Danaher Corporation by 10.8% in the second quarter. Dynamic Technology Lab Private Ltd now owns 8,000 shares of the conglomerate’s stock worth $676,000 after buying an additional 777 shares during the period. WINTON GROUP Ltd boosted its stake in Danaher Corporation by 216.7% in the second quarter. WINTON GROUP Ltd now owns 13,221 shares of the conglomerate’s stock worth $1,116,000 after buying an additional 9,046 shares during the period. Gofen & Glossberg LLC IL boosted its stake in Danaher Corporation by 2.2% in the second quarter. Gofen & Glossberg LLC IL now owns 198,688 shares of the conglomerate’s stock worth $16,767,000 after buying an additional 4,195 shares during the period. Finally, Public Employees Retirement System of Ohio boosted its stake in Danaher Corporation by 2.7% in the second quarter. Public Employees Retirement System of Ohio now owns 421,369 shares of the conglomerate’s stock worth $35,559,000 after buying an additional 11,154 shares during the period. Institutional investors and hedge funds own 76.12% of the company’s stock.

DHR has been the subject of a number of analyst reports. Deutsche Bank AG restated a “buy” rating and set a $97.00 price objective on shares of Danaher Corporation in a research note on Wednesday, June 21st. Credit Suisse Group restated a “buy” rating and set a $93.00 price objective on shares of Danaher Corporation in a research note on Wednesday, May 24th. BTIG Research restated a “buy” rating and set a $92.00 price objective on shares of Danaher Corporation in a research note on Sunday, April 23rd. Citigroup Inc. set a $96.00 price objective on Danaher Corporation and gave the stock a “buy” rating in a research note on Friday, July 21st. Finally, Zacks Investment Research upgraded Danaher Corporation from a “hold” rating to a “buy” rating and set a $91.00 price objective for the company in a research note on Friday, July 28th. One analyst has rated the stock with a sell rating, three have given a hold rating, thirteen have issued a buy rating and one has given a strong buy rating to the stock. The company has a consensus rating of “Buy” and an average target price of $91.76.

Danaher Corporation Company Profile

Danaher Corporation (Danaher) designs, manufactures and markets professional, medical, industrial and commercial products and services. The Company operates through four segments: Life Sciences, which offers a range of research tools that scientists use to study the basic building blocks of life, including genes, proteins, metabolites and cells, in order to understand the causes of disease, identify new therapies and test new drugs and vaccines; Diagnostics; which offers analytical instruments, reagents, consumables, software and services; Dental, which provides products that are used to diagnose, treat and prevent disease and ailments of the teeth, gums and supporting bone, and Environmental & Applied Solutions, which consists of various lines of business, including water quality and product identification.

Insider Buying and Selling by Quarter for Danaher Corporation (NYSE:DHR)

Receive News & Stock Ratings for Danaher Corporation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Danaher Corporation and related stocks with our FREE daily email newsletter.